INTERNATIONAL PATENT: HANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO., LTD FILES APPLICATION FOR "NOVEL NLRP3 INFLAMMASOME INHIBITORS"

GENEVA, Feb. 8 -- HANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO., LTD (Room 301/302, No. 4 Bldg, Hexiang Science & Technology Center, Qiantang DistrictHangzhou, Zhejiang 310018) filed a patent application (PCT/CN2025/110535) for "NOVEL NLRP3 INFLAMMASOME INHIBITORS" on Jul 25, 2025. With publication no. WO/2026/026674, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LIANG, Congxin (Room 301, No. 4 Bldg, Hexiang Science & Technology Center, Qiantang DistrictHangzhou, Zhejiang 310018), LI, Shuangjiang (Room 301, No. 4 Bldg, Hexian...